Diversified Healthcare Trust Earnings Call Signals Turnaround

Diversified Healthcare Trust ((DHC)) has held its Q1 earnings call. Read on for the main highlights of the call.

Diversified Healthcare Trust used its latest earnings call to underscore a clear shift from stabilization to growth, with management emphasizing strong momentum in its senior housing portfolio and solid gains across the broader platform. While leverage and capital needs remain elevated, executives stressed that operational gains, improved liquidity, and a recent credit upgrade are meaningfully de‑risking the story and supporting a more constructive outlook.

FFO Beat Underscores Earnings Momentum

Diversified Healthcare Trust reported normalized funds from operations of $33.1 million, or $0.14 per share, alongside adjusted EBITDAre of $74 million, with both metrics described as well ahead of analyst expectations. Management framed this beat as evidence that operating initiatives and portfolio repositioning are flowing through to the bottom line, setting a stronger base for future growth.

NOI Growth Signals Broad-Based Improvement

Consolidated net operating income reached $75.9 million, reflecting a 4.7% year‑over‑year increase, while same‑property cash NOI jumped 8.6% year over year and 7.8% sequentially. Executives highlighted that this broad‑based NOI expansion spans both senior housing and medical office assets, suggesting the recovery is not reliant on a single segment or one‑time items.

SHOP Portfolio Delivers Double-Digit NOI Gains

The senior housing operating portfolio (SHOP) remained the key growth engine, with same‑property NOI rising 13.5% year over year to $44.3 million and occupancy increasing 110 basis points to 82.4%. Average monthly rates grew roughly 5.9% and same‑property NOI margins expanded 160 basis points to 14.9%, underscoring the combination of pricing power and improving scale in the platform.

Cost Controls Drive Margin Expansion

Management detailed substantial expense wins, including nearly a 35% reduction in contract labor year over year and a 370 basis‑point sequential drop in dietary costs. Adjusted labor costs declined 70 basis points sequentially and same‑property expense growth moderated by 350 basis points year over year and 120 basis points versus last quarter, collectively supporting sustained margin improvement.

Targeted Growth Projects Promise High Returns

The company outlined a disciplined capital deployment pipeline spanning 16 communities, with an initial six projects totaling approximately $20 million to add about 150 units. These expansions are expected to be immediately accretive, with projected returns starting in the mid‑teens and a cost per unit well below estimated replacement cost, positioning DHC for efficient growth.

Medical Office & Life Science Portfolio Remains a Pillar

In its medical office and life science segment, same‑property occupancy climbed 60 basis points to 95.3% and NOI reached $25.4 million, up 3.7% year over year and 4.8% sequentially. The REIT signed 169,000 square feet of new and renewal leases at rents roughly 12% above prior levels with a 9.5‑year weighted average term, and management noted an additional 390,000 square feet of leases executed after quarter end.

Liquidity and Balance Sheet Flexibility Improve

DHC closed the quarter with total liquidity of $272 million, including $122 million of cash and a fully available $150 million revolving credit facility. With 197 unencumbered properties representing about 64% of gross book value and no debt maturities until 2028 after recent 2025-related actions, management emphasized increased flexibility to fund investments and navigate volatility.

Leverage and Coverage Trend in the Right Direction

Net debt to annualized adjusted EBITDAre improved to 7.8 times from 8.8 times a year ago, while the adjusted EBITDAre‑to‑interest coverage ratio rose to 2.0 times from 1.3 times. Management reiterated a near‑term leverage goal of 6.5 to 7.5 times, acknowledging that leverage and coverage remain above ideal levels but are on a clear improving trajectory.

Capital Recycling Sharpens Portfolio Focus

The REIT continued to recycle capital by selling 13 unencumbered non‑core SHOP communities for $23 million, reallocating proceeds into higher‑return opportunities. DHC also exercised land lease purchase options on two properties for $14.5 million, eliminating ground rent and capturing full asset economics, with expected low‑ to mid‑teens returns on these land buys.

Credit Upgrade and Market Outperformance Boost Confidence

Moody’s upgraded DHC’s corporate family rating to B3 from Caa1 with a positive outlook, reflecting improved operations and balance sheet health. Management also highlighted that the company’s shares have appreciated roughly 60% year to date, far outpacing the S&P 500 and the VNQ index, signaling growing investor confidence in the turnaround.

Guidance Reaffirmed Despite CapEx and Leverage Needs

The company reaffirmed full‑year 2026 guidance, calling for SHOP NOI of $175 million to $185 million, medical office and life science NOI of $94 million to $98 million, and triple‑net NOI of $28 million to $30 million. Adjusted EBITDAre is projected at $290 million to $305 million and normalized FFO at $0.52 to $0.58 per share, while recurring CapEx is expected at $100 million to $115 million, including significant SHOP maintenance and refresh spending.

Risks: Elevated Leverage and Modest Coverage

Despite progress, leverage remains elevated at 7.8 times net debt to annualized adjusted EBITDAre, still above management’s target range and keeping deleveraging as a near‑term priority. Interest coverage, though improved to 2.0 times, remains modest relative to more conservative REIT benchmarks, leaving the company somewhat sensitive to higher rates or earnings volatility.

Occupancy Seasonality Tempers Near-Term SHOP Gains

SHOP same‑property occupancy was flat sequentially at 82.4%, with management citing seasonal patterns and the timing of operator transitions as temporary headwinds. They expect occupancy to grind higher later in the year, but investors should anticipate some quarter‑to‑quarter noise as new operators ramp and seasonal demand trends normalize.

MO/LS Lease Rollover and Vacancy Risk

While the medical office and life science portfolio is performing well, about 9% of annualized rental income is scheduled to expire through 2026, creating rollover risk. Management flagged approximately 304,000 square feet, representing around 4.9% of annualized rental income, that is expected to vacate, emphasizing the importance of proactive leasing to preserve occupancy and cash flow.

High Recurring CapEx Remains a Structural Drag

Recurring capital expenditures are projected at $100 million to $115 million for 2026, with SHOP recurring CapEx alone running $80 million to $90 million and maintenance around $3,500 per unit. Although management expects this maintenance run‑rate to decline over time, these ongoing investment requirements remain a structural claim on cash and a key consideration for long‑term returns.

G&A and One-Time Items Add Earnings Noise

First‑quarter general and administrative expense included $6.6 million of incentive management fees tied to strong stock performance, pushing reported G&A higher than underlying trends. Excluding these fees, G&A would have been $7.4 million, and management cautioned that such fees can fluctuate with the share price, while operator transitions and below‑the‑line transaction costs also introduce some near‑term earnings volatility.

Forward Guidance Highlights Occupancy and Rate Upside

Management reaffirmed guidance calling for roughly a 300‑basis‑point year‑over‑year increase in SHOP occupancy and rate growth above 5%, underpinning expectations that SHOP NOI will track ahead of initial plans. They anticipate incremental NOI uplift in the second quarter, a modest drag in the third quarter, and stronger performance in the fourth quarter, while reiterating a near‑term leverage target of 6.5 to 7.5 times supported by $272 million of liquidity.

Diversified Healthcare Trust’s call painted a picture of a REIT that is steadily rebuilding earnings power and balance sheet strength, with the SHOP portfolio and MO/LS platform both contributing to growth. While leverage, interest coverage, lease rollover and CapEx needs remain important watch points, management’s execution and reaffirmed guidance suggest the company’s recovery is gaining traction, keeping the stock firmly on the radar of yield‑ and turnaround‑focused investors.